| __timestamp | Amneal Pharmaceuticals, Inc. | Mesoblast Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 55305000 |
| Thursday, January 1, 2015 | 136870000 | 77593000 |
| Friday, January 1, 2016 | 204747000 | 50013000 |
| Sunday, January 1, 2017 | 191938000 | 58914000 |
| Monday, January 1, 2018 | 210451000 | 65927000 |
| Tuesday, January 1, 2019 | 202287000 | 59815000 |
| Wednesday, January 1, 2020 | 190585000 | 56188000 |
| Friday, January 1, 2021 | 209563000 | 53012000 |
| Saturday, January 1, 2022 | 200046000 | 32815000 |
| Sunday, January 1, 2023 | 167778000 | 27189000 |
| Monday, January 1, 2024 | 25353000 |
Cracking the code
In the competitive world of pharmaceuticals, innovation is key. Amneal Pharmaceuticals, Inc. and Mesoblast Limited are two companies that have consistently invested in research and development (R&D) over the past decade. From 2014 to 2023, Amneal Pharmaceuticals has shown a robust commitment to innovation, with R&D expenses peaking in 2018 at approximately $210 million. This represents a significant increase of nearly 97% from their 2014 investment. In contrast, Mesoblast Limited's R&D spending reached its highest in 2015, with a more modest peak of around $78 million, marking a 40% increase from 2014. However, by 2023, both companies saw a decline in their R&D investments, with Amneal's expenses dropping to about $168 million and Mesoblast's to approximately $27 million. This trend highlights the dynamic nature of the pharmaceutical industry and the varying strategies companies employ to stay ahead.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Blueprint Medicines Corporation and Mesoblast Limited
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Mesoblast Limited: Examining Key Revenue Metrics
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Amicus Therapeutics, Inc. vs Mesoblast Limited
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited
Research and Development Investment: Mesoblast Limited vs MannKind Corporation
R&D Spending Showdown: Mesoblast Limited vs Galapagos NV